Board Performance · 2024
In this section11 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Evaluation of Board & Subcommittee Performance3 items
- Meeting Attendance & Remuneration3 items
- Supervision of Subsidiaries & Associated Companies4 items
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The company recognizes the importance of conducting business with integrity, transparency, and accountability, adhering to good corporate governance principles to enhance organizational efficiency. To ensure fair business operations and prevent conflicts of interest, the company has established a Conflict of Interest Prevention Policy, along with strict operational guidelines as follows:
• The company shall not provide loans or guarantees to directors or businesses in which a director holds more than 50% of shares, except as part of company benefits.
• Directors shall not engage in businesses that compete with the company unless approved by the shareholders' meeting before their appointment.
• Directors and executives must not exploit company opportunities or confidential information for personal or third-party benefit, including engaging in competitive or related businesses.
• Directors and executives must not participate in discussions or voting on matters that involve them and could create a conflict of interest with the company. If a transaction is necessary for the company's benefit, it must be conducted on an Arm’s Length Basis as if dealing with an external party.
• Directors and executives must disclose any personal interest in contracts entered into by the company.
• Directors and executives must submit an annual disclosure report on conflicts of interest or whenever a new situation arises.
• Transactions involving the purchase or sale of goods, assets, or other items between a director and the company must be disclosed and approved by the Board of Directors.
• Independent directors must be involved in reviewing and approving conflict-of-interest matters to ensure fair decision-making.
• Directors, executives, and employees who have access to internal information must refrain from misusing such information for personal gain or improperly disclosing it to others.
Ensuring Transparency in Related Transactions, the company places great importance on ensuring transparency and prioritizing the company's best interests when evaluating transactions that may involve conflicts of interest. The company has established the following preventive principles for related-party transactions and intercompany dealings:
1. Directors and executives must disclose to the company any relationships or related transactions that may create a conflict of interest.
2. Avoid engaging in transactions with directors, executives, or related parties that may lead to conflicts of interest with the company. If such transactions are necessary, they must be submitted to the Audit Committee for review before seeking approval from the Board of Directors or the shareholders' meeting (as applicable), in accordance with Securities and Exchange Commission (SEC) and Stock Exchange of Thailand (SET) regulations and good corporate governance principles.
3. Executives and employees must strictly adhere to company regulations and business ethics, ensuring the company maintains its credibility and trustworthiness among all stakeholders. The company actively promotes awareness and compliance among employees through company-wide communication and training.
The company enforces these policies and practices rigorously and transparently to prevent conflicts of interest, ensuring that all business activities are conducted responsibly and in line with the highest ethical standards to build trust among all stakeholders.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The company conducts its business with a strong focus on shareholders, investors, stakeholders, the economy, and society. To ensure proper governance, the company enforces strict oversight of directors, sub-committee members, executives, and employees in handling non-public internal information and preventing its misuse for personal gain. This is in compliance with the Securities and Exchange Act B.E. 2535 (1992) (including amendments) and the Stock Exchange of Thailand (SET) regulations on information disclosure for listed companies.
Furthermore, the company has implemented an Internal Information Usage Policy, serving as a guideline for managing internal information to ensure that directors, executives, and employees understand and comply with the correct procedures. Over the past year, the company has actively monitored the use of internal information through corporate governance measures, which include: restricting the number of individuals with access to internal information, defining access levels to company information to enhance data security, implementing secure data storage and processing systems Requiring employees to sign confidentiality agreements, informing directors and executives of their responsibilities regarding internal information handling. These measures reinforce the company’s commitment to transparency, data security, and regulatory compliance in managing sensitive corporate information.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The company has established an Anti-Corruption and Fraud Policy as a guideline for conducting business with integrity, emphasizing responsibility towards society and all stakeholders. This policy is implemented within the framework of good corporate governance and ethical business practices, ensuring transparency, strong internal controls, and audit mechanisms to minimize opportunities for fraud and corruption within the organization. To demonstrate its commitment to fighting corruption in all forms, as previously outlined in Section 6.1.2: Policies and Practices Regarding Shareholders and Stakeholders, the company requires that directors, sub-committee members, executives, and employees perform their duties without abusing their authority—directly or indirectly—for personal gain or for the benefit of others through fraudulent means. This includes refraining from soliciting, engaging in, or facilitating corruption in any form that results in undue benefits. The company actively communicates and provides training on its anti-corruption policies and practices to directors, sub-committee members, executives, and employees. Additionally, it has established whistleblowing and complaint channels to report suspected fraudulent or corrupt activities, with confidentiality and protection measures for whistleblowers. If the company detects any bribery, fraud, or corruption, or if any individual is found to have violated the anti-corruption policy, such actions will be considered a serious violation of company regulations and will be subject to disciplinary action. If the act is illegal, the violator may also face legal consequences. As of December 31, 2024, the company has not received any reports of bribery, fraud, or corruption.
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of appropriateness in anti-corruption |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The company has established a policy on complaints and whistleblowing regarding misconduct, applicable to directors, members of sub-committees, executives, employees, customers, contractors, and stakeholders. The company has set up a reliable process, methods, and channels for employees, customers, contractors, and stakeholders to report any misconduct or wrongdoing they have witnessed or become aware of. Such misconduct may involve directors, sub-committee members, executives, employees, representatives, or agents of the company. Additionally, the company has implemented a policy to protect whistleblowers, witnesses, and other informants from disciplinary actions or other adverse consequences from supervisors or executives. All complaints or whistleblowing reports must be made in good faith and must not be intended as retaliation or malicious accusations. The Board of Directors has established channels for reporting concerns or complaints from stakeholders who believe they have been affected by the company’s operations or have witnessed employees engaging in fraud or illegal activities. Reports can be submitted through the following channels:
(1) Internal Reporting Channels:
Channel 1: Report directly to the supervisor in the chain of command and/or the department responsible for overseeing compliance with the company's code of conduct and ethical standards.
Channel 2: Suggestion Box.
Channel 3: Email: auditcommittee@bangkokgenomics.com.
(2) External Reporting Channels:
Channel 1: By mail, addressed to:
Chairman of the Audit Committee
Bangkok Genomics Innovation Public Company Limited
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei District, Bangkok 10110, Thailand
Channel 2: By email: auditcommittee@bangkokgenomics.com.
Since the implementation of the whistleblowing policy until December 31, 2024, the company has not received any reports of misconduct or wrongdoing.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
5
Rights of Minority Shareholders on Director Appointment
The Board of Directors is responsible for nominating and appointing directors, executives with management authority, and heads of key business units. The board establishes policies for recruiting and selecting qualified individuals to serve as directors, members of subcommittees, or senior executives. Candidates undergo background checks and qualification assessments before being presented to the Shareholders' Meeting for approval. The shareholders determine the structure and compensation of the Board, ensuring that it reflects the duties and responsibilities of each director in accordance with the company's charter, policies, regulations, and applicable laws.
The appointment of directors follows the company's articles of association and relevant laws, utilizing the one-share, one-vote principle for director elections. Shareholders may allocate all of their votes to a single candidate or distribute them among multiple candidates but cannot assign varying vote counts to different candidates. In the case of a tie exceeding the number of available board seats, the Chairman of the meeting shall cast the deciding vote. The appointment process must be transparent, considering the nominee’s educational background, experience, and qualifications to ensure an informed decision by the Board and shareholders. Additionally, the right of minority shareholders to nominate individuals for board elections is currently under review.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
The Board of Directors selects independent directors based on their qualifications, work experience, and other relevant factors. The selected candidates are then presented to the shareholders' meeting for appointment as directors of the Company. The Company has a policy to appoint independent directors at a minimum ratio of one-third (1/3) of the total number of directors, with no fewer than three (3) independent directors. Independent directors must be free from the control of management and major shareholders and must not have any financial or operational interests in the Company. Additionally, they must meet all relevant qualifications prescribed by the Capital Market Supervisory Board (SEC) and other applicable laws. Currently, the Board of Directors consists of 11 members, including four (4) independent directors, which is no less than one-third of the total number of directors. The qualifications of the Company’s independent directors can be summarized as follows:
1. Must hold no more than 1% of the total voting shares of the Company, its parent company, subsidiaries, associates, major shareholders, or controlling persons, including shares held by persons related to the independent director.
2. Must not be, nor have ever been, a director involved in management, an employee, a staff member, a salaried advisor, or a controlling person of the Company, its parent company, subsidiaries, associates, subsidiaries of the same tier, major shareholders, or controlling persons. Exceptions apply if such status has been terminated for at least two years before the appointment. However, this restriction does not apply to independent directors who were previously government officials or advisors to a government agency that is a major shareholder or controlling person of the Company.
3. Must not have blood or legal relationships, such as being a parent, spouse, sibling, child, or spouse of a child, of another director, executive, major shareholder, controlling person, or any individual who is nominated to be a director, executive, or controlling person of the Company or its subsidiaries.
4. Must not have or have had any business relationship with the Company, its parent company, subsidiaries, associates, major shareholders, or controlling persons that could interfere with their independent judgment. Additionally, they must not have been a major shareholder or controlling person of the Company unless the relationship ended at least two years before the appointment.
5. May hold directorships in other companies, provided that such positions do not interfere with their responsibilities as an independent director of the Company and comply with the regulations of the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET).
6. Must not engage in any business that is similar to or competes with the Company’s business, whether as a sole proprietor, partner in a general partnership, unlimited liability partner in a limited partnership, director of a private company, or director of another company conducting similar or competing business, whether for their own benefit or the benefit of others, unless they have disclosed such involvement to the shareholders’ meeting before their appointment.
7. Must meet the independence criteria as prescribed by the Capital Market Supervisory Board and comply with the same standards applicable to audit committee members as specified by the SEC and SET. They must be able to act in the best interests of all shareholders equally, without conflicts of interest. Additionally, they must be able to attend Board meetings and provide independent opinions.
Did Any Independent Director Have a Business or Professional Relationship?
No
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
The company places great importance on good corporate governance policies to foster sustainable growth with a strong emphasis on governance principles. To ensure effective oversight, the company has established charters that define the roles, duties, and responsibilities of the Board of Directors and subcommittees, setting key policies to guide corporate operations. These policies serve as a framework for executives to implement in managing the organization efficiently while adhering to the company's corporate governance standards. To reinforce these governance principles, the Board of Directors and subcommittees conduct self-assessments at least once a year. This evaluation process allows the Board and subcommittees to jointly review their performance, identify areas for improvement, and ensure that their duties, roles, and responsibilities are carried out effectively. The assessment should be conducted at both committee and individual levels to enhance accountability and continuous development.
Evaluation of Board Performance in the Past Year
For the 2024 performance evaluation of the Board of Directors, the Board conducted assessments at both the committee level and individual level. The evaluation results were collectively reviewed and acknowledged in the Board meeting, allowing the Board to establish strategies for improvement and development of both the Board of Directors and its subcommittees moving forward.
Evaluation Results
| Evaluated Body | Group — Carried Out? | Group — Grade / Average Score | Group — Grade / Full Score | Individual (Self-Assessment) — Carried Out? | Individual (Self-Assessment) — Grade / Average Score | Individual (Self-Assessment) — Grade / Full Score | Cross (Assessing Other Directors) — Carried Out? |
|---|---|---|---|---|---|---|---|
| Board Of Director | Y | 4.67 | 5 | Y | 4.76 | 5 | N |
| Audit Committee | Y | 4.68 | 5 | N | N |
Meeting Attendance & Remuneration
Justification for Directors' Non-Attendance
In 2024, some Board members were unable to attend certain Board meetings due to urgent and critical business commitments that directly impacted the company's strategic direction. These commitments included meetings and negotiations with major partners, investors, and business allies, which were crucial for expanding opportunities and driving corporate development. Despite their absence from some meetings, the Board members actively monitored the meeting agendas, provided preliminary input and opinions, and ensured the continuity of the Board's decision-making process. They remained committed to fulfilling their duties under corporate governance principles and continued to prioritize their oversight role in steering the company toward sustainable growth.
Types of Remuneration of the Board of Directors
At the Annual General Meeting of Shareholders for 2024, held on February 29, 2024, a resolution was passed to determine the compensation for the Board of Directors and subcommittees as follows:
Monthly Remuneration of the Board of Directors (Baht/person)
• Chairman of the Board 50,000 Baht
• Directors 40,000 Baht
Meeting Allowance for sub-committees (Audit Committee and Executive Committee) (Baht/person)
• Chairman of the Board 20,000 Baht
• Directors 15,000 Baht
Note: Directors who serve as the company's executive shall receive compensation only in their capacity as executives and will not receive any remuneration in their capacity as board members.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The company has a governance and oversight mechanism for its subsidiaries and affiliated companies by appointing representatives, who are either directors or executives of the company, to serve as directors in all subsidiaries and affiliated companies. This ensures proper supervision and alignment of business operations with the company's core policies while safeguarding the best interests of the subsidiaries and affiliated companies.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Other important transactions |
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
For the year 2024, ending on December 31, 2024, the Audit Committee reviewed and considered the following key matters:
1. Reviewed the financial reporting system and financial disclosures to ensure compliance with financial reporting standards.
2. Evaluated and provided opinions on related party transactions, asset acquisitions and disposals, or transactions that may present conflicts of interest.
3. Reviewed the risk assessment system to ensure alignment with both internal and external business environments.
4. Assessed and provided recommendations on the internal control system, ensuring compliance with internal control framework guidelines.
5. Reviewed and approved the internal audit plan, internal audit workforce, and the appointment of the Head of Internal Audit.
6. Considered and selected the Company’s external auditors, including determining annual audit fees, and ensured that the Company’s operations comply with relevant regulations and legal requirements applicable to its business.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
For the year 2024, ending on December 31, 2024, the Executive Committee reviewed and considered the following key matters:
1. Established the Company's vision, mission, business objectives, and strategies, including the annual budget and investment budget.
2. Reviewed and approved investments and expenditures within the Executive Committee’s authority, ensuring alignment with the Company’s direction and objectives.
3. Reviewed, advised on, and approved operational plans to support the execution of the Company’s business strategies and objectives.
4. Monitored and assessed market conditions and competitive landscape to ensure strategic alignment and responsiveness.
